sesamin has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, T; Ito, N; Saito, H; Seki, S; Ueda, F | 1 |
| Farbood, Y; Ghaderi, S; Khorsandi, L; Khoshnam, SE; Rashno, M; Sarkaki, A | 1 |
1 trial(s) available for sesamin and Cognitive Decline
| Article | Year |
|---|---|
Effects of Composite Supplement Containing Astaxanthin and Sesamin on Cognitive Functions in People with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Aged; Cognitive Dysfunction; Dietary Supplements; Dioxoles; Double-Blind Method; Female; Humans; Lignans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Treatment Outcome; Xanthophylls | 2018 |
1 other study(ies) available for sesamin and Cognitive Decline
| Article | Year |
|---|---|
Sesamin: A promising protective agent against diabetes-associated cognitive decline in rats.
Topics: Animals; Antioxidants; Apoptosis; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Dioxoles; Glutathione Peroxidase; Hippocampus; Insulin; Lignans; Male; Malondialdehyde; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2019 |